Current position: Reporting Centre > 医药健康 |
Detailed introductionAccording to statistics and forecasts from Easseen Research, global pregabalin market sales will reach 100 million yuan in 2024, and are expected to reach 100 million yuan in 2030, with a compound annual growth rate (CAGR) of % (2024-2030 ).According to product type, it can be divided into pregabalin oral solution, pregabalin capsules, and pregabalin sustained-release tablets. The downstream application markets of pregabalin include hospitals and clinics. The report will conduct a detailed analysis of market sales, revenue, share, and growth rates of different types and applications. From the perspective of manufacturers, major manufacturers include Jiangxi Kerui Pharmaceutical Co., Ltd., Beijing Baiya Joint Pharmaceutical Research Institute Co., Ltd., Jichuan Pharmaceutical Group Co., Ltd., Guangzhou Daguang Pharmaceutical Co., Ltd., Chengdu Huide Pharmaceutical Technology Co., Ltd., etc. . The industry concentration ratios CR3, CR5, and CR10 in 2024 will be displayed in charts in the report. For leading companies, the report conducts detailed and in-depth research on the TOP 3 companies, including company development history, product technical characteristics, future development plans, etc. This report studies the production capacity, output, sales volume, sales, price and future trends of Pregabalin in the global and Chinese markets. Focus on analyzing the product characteristics, product specifications, prices, sales volume, sales revenue of major manufacturers in the Chinese market and the market shares of major manufacturers in the global and Chinese markets. Historical data is from 2019 to 2023, and forecast data is from 2024 to 2030. The report analyzes and forecasts the market size, sales volume, share, development characteristics, etc. in North America, Europe, Asia, Latin America, the Middle East and Africa. Help companies understand the market status and development characteristics of different regions, provide data support for corporate business decisions, and help companies formulate global development strategies. Key takeaways from this report: Market space: Pregabalin market size, growth rate forecast; segmented product types and application market sales, revenue and growth rate. Industry chain situation: analysis of the main upstream raw material suppliers and downstream main customer needs of pregabalin manufacturers. Manufacturer analysis: Sales volume, revenue, market share, product features, SWOT analysis, etc. of leading global and Chinese pregabalin companies. Economic environment analysis: the impact of the international situation on the industry, current economic environment, industry policies, opportunities and risks, and development trends. Main manufacturers of this report: Jiangxi Kerui Pharmaceutical Co., Ltd. Beijing Bai Ya United Pharmaceutical Research Institute Co., Ltd. Jichuan Pharmaceutical Group Co., Ltd. Guangzhou Daguang Pharmaceutical Co., Ltd. Chengdu Huide Pharmaceutical Technology Co., Ltd. Baker Norton (Zhejiang) Pharmaceutical Co., Ltd. Huadong Pharmaceutical (Xi'an) Bo Hua Pharmaceutical Co., Ltd. Hefei Enruite Pharmaceutical Co., Ltd. Sichuan Zilugong Pharmaceutical Co., Ltd. Ningbo Menohua Tiankang Pharmaceutical Co., Ltd. Shandong Buchang Pharmaceutical Co., Ltd. Aomei Pharmaceutical (Hainan) Co., Ltd. Ningbo Shuangcheng Pharmaceutical Co., Ltd. Tiandi Hengyi Pharmaceutical Co., Ltd. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Hunan Sailong Pharmaceutical (Changsha) Co., Ltd. Qilu Pharmaceutical (Hainan) Co., Ltd. Segmented by product type: Pregabalin Oral Solution Pregabalin Capsules Pregabalin Sustained Release Tablets Segmented by application: hospital clinic Report chapter content: Chapter 1: Report statistical scope, product segment market types and applications, industry market size and growth rate, etc. Chapter 2: Market capacity, output, sales volume, revenue, share, price and forecast data of major regions in the global market Chapter 3: China market sales volume, revenue, market share, price data, etc. Chapter 4: Sales volume, revenue and market share data of major global and Chinese manufacturers, development history of leading companies, product and technology introduction, etc. Chapter 5: Price, sales volume, revenue, market share and future forecast data of different product types in the global market Chapter 6: Price, sales volume, revenue, market share and future forecast data of different application markets in the global market Chapter 7: Price, sales volume, revenue, market share and future forecast data of different product types in the Chinese market Chapter 8: Price, sales volume, revenue, market share and future forecast data of different application markets in the Chinese market Chapter 9: Company introduction, product introduction, market sales, revenue, growth rate, gross profit margin and other data of major manufacturers, corporate SWOT analysis and latest developments, etc. Chapter 10: Industry supply chain analysis, including upstream and downstream industry chains, production processes, sales models, etc. Chapter 11: Opportunities, risks, trends, etc. of industry development Chapter 12: Analysis of industry development environment, including overall economic environment, industry policies, international situation, etc. Chapter 13: Research Conclusions
Report directory
Text table of contents 1 Pregabalin industry market overview 1.1 Pregabalin product definition and statistical scope 1.2 According to different product types, pregabalin is mainly divided into the following categories: 1.2.1 Pregabalin Oral Solution 1.2.2 Pregabalin capsules 1.2.3 Pregabalin extended-release tablets 1.3 According to different application markets, pregabalin is mainly divided into the following segmented application market types: 1.3.1 Hospital 1.3.2 Clinic 1.4 Development status and future development trends of pregabalin in the global market 1.4.1 Global Market Pregabalin Revenue and Growth Rate (RMB 100 million) 1.4.2 Pregabalin sales volume and growth rate in the global market (10,000 pieces) 2 Analysis of the overall size of the global pregabalin market 2.1 Global Pregabalin Sales and Growth Forecast (2019-2030) 2.1.1 Global Pregabalin Sales and Growth Rate Forecast (2019-2030) 2.1.2 Global pregabalin revenue and growth rate forecast (2019-2030) 2.2 Pregabalin sales volume, market share and development trends in major global regions (2019-2030) 2.2.1 Pregabalin sales and growth rate in major global regions (2019-2024) 2.2.2 Pregabalin sales and growth forecast in major global regions (2025-2030) 2.2.3 Pregabalin sales market share forecast in major global regions (2019-2030) 2.3 Pregabalin revenue, market share and development trends in major global regions (2019-2030) 2.3.1 Pregabalin revenue and growth rate in major global regions (2019-2024) 2.3.2 Pregabalin revenue and growth forecast in major global regions (2025-2030) 2.3.3 Pregabalin revenue market share forecast in major global regions (2019-2030) 2.4 Global market sales, production capacity, output and capacity utilization of pregabalin (2019-2030) 2.4.1 Pregabalin sales volume, output and sales-to-production ratio in the global market (2019-2030) & (10,000 pieces) 2.4.2 Global market pregabalin production capacity, volume and capacity utilization (2019-2030) & (10,000 pieces) 2.5 Global Market Pregabalin Price Trend (2019-2030) 3 Analysis of China’s Pregabalin Market Size 3.1 Pregabalin sales and growth rate forecast in China (2019-2030) 3.1.1 Pregabalin sales and growth rate forecast in China (2019-2030) 3.1.2 Pregabalin revenue and growth rate forecast in China (2019-2030) 3.2 Global market share of pregabalin in the Chinese market (2019-2030) 3.2.1 Global market share of pregabalin sales in the Chinese market (2019-2030) & (10,000 pieces) 3.2.2 Global market share of pregabalin revenue in the Chinese market (2019-2030) & (100 million yuan) 3.3 Pregabalin price trend in the Chinese market (2019-2030) 4 Market analysis of major global and Chinese pregabalin manufacturers 4.1 Sales volume and market share of major pregabalin manufacturers in the global market 4.1.1 Sales volume and market share of major pregabalin manufacturers in the global market (2019-2024) & (10,000 pieces) 4.1.2 Revenue and market share of major pregabalin manufacturers in the global market (2019-2024) & (100 million yuan) 4.1.3 Revenue ranking of major pregabalin manufacturers in the global market in 2024 (100 million yuan) 4.1.4 Global Market Pregabalin Price Trend (2019-2024) & (Yuan/Piece) 4.2 Sales volume and market share of pregabalin major manufacturers in the Chinese market 4.2.1 Sales volume and market share of pregabalin major manufacturers in the Chinese market (2019-2024) & (10,000 pieces) 4.2.2 Revenue and market share of major pregabalin manufacturers in the Chinese market (2019-2024) & (100 million yuan) 4.2.3 Revenue ranking of major pregabalin manufacturers in the Chinese market in 2024 (100 million yuan) 4.2.4 Pregabalin price trend in the Chinese market (2019-2024) & (yuan/unit) 4.3 Introduction to major manufacturers of pregabalin 4.4 Pregabalin industry concentration analysis and introduction of leading companies 4.4.1 Preba Forestry Concentration Analysis: Market Revenue Share of the Global Top 5 Manufacturers in 2024 4.4.2 Development history and market position of TOP 3 companies 4.4.3 Introduction to the main products and technologies of the TOP 3 companies 5 Global Pregabalin Market Analysis of Different Types of Products 5.1 Global Pregabalin Market Sales Volume and Market Share of Different Types of Products 5.1.1 Global Pregabalin market sales and market share of different types of products (2019-2024) & (10,000 pieces) 5.1.2 Global sales and market share forecast of different types of pregabalin products (2025-2030) & (10,000 pieces) 5.2 Global Pregabalin market size and share of different types of products (100 million yuan) 5.2.1 Global Pregabalin Product Scale and Market Share by Type (2019-2024) 5.2.2 Global Pregabalin Product Scale and Market Share Forecast of Different Types (2024-2029) 5.3 Global price trends of different types of pregabalin products (2019-2030) & (yuan/piece) 6 Global Pregabalin Market Analysis by Different Applications 6.1 Global Pregabalin Sales Volume and Market Share by Application 6.1.1 Global Pregabalin sales volume and market share by application (2019-2024) & (10,000 pieces) 6.1.2 Global sales and share forecast of pregabalin by different applications (2025-2030) 6.2 Global pregabalin revenue and share by application (100 million yuan) 6.2.1 Global pregabalin revenue and share by application (2019-2024) (100 million yuan) 6.2.2 Global Pregabalin Revenue and Market Share Forecast by Different Applications (2025-2030) 6.3 Global price trends of pregabalin products for different applications (2019-2030) & (yuan/unit) 7 Market analysis of different types of pregabalin products in China 7.1 Market sales volume and market share of different types of pregabalin products in China 7.1.1 Market sales and market share of different types of pregabalin products in China (2019-2024) & (10,000 pieces) 7.1.2 Sales volume and market share forecast of different types of pregabalin products in China (2025-2030) & (10,000 pieces) 7.2 Market size and share of different types of pregabalin products in China (100 million yuan) 7.2.1 Size and market share of different types of pregabalin products in China (2019-2024) 7.2.2 Forecast of the scale and market share of different types of pregabalin products in China (2024-2029) 7.3 Price trends of different types of pregabalin products in China (2019-2030) & (yuan/unit) 8 Analysis of different application markets of pregabalin in China 8.1 Pregabalin sales volume and market share by application in China 8.1.1 Pregabalin sales volume and market share by application in China (2019-2024) & (10,000 pieces) 8.1.2 Sales volume and share forecast of pregabalin by different applications in China (2025-2030) 8.2 Revenue and share of pregabalin in different applications in China (100 million yuan) 8.2.1 China’s pregabalin revenue and share by application (2019-2024) (100 million yuan) 8.2.2 Pregabalin revenue and market share forecast by different applications in China (2025-2030) 8.3 China’s price trend of pregabalin products for different applications (2019-2030) & (yuan/piece) 9 Analysis of major manufacturers of pregabalin 9.1 Jiangxi Kerui Pharmaceutical Co., Ltd. 9.1.1 Company Profile of Jiangxi Kerui Pharmaceutical Co., Ltd. 9.1.2 Jiangxi Kerui Pharmaceutical Co., Ltd. Pregabalin Product Introduction 9.1.3 Jiangxi Kerui Pharmaceutical Co., Ltd. Pregabalin product business revenue (2019-2024) 9.1.4 SWOT analysis of Jiangxi Kerui Pharmaceutical Co., Ltd. 9.1.5 Jiangxi Kerui Pharmaceutical Co., Ltd. News 9.2 Beijing Baiya Joint Drug Research Institute Co., Ltd. 9.2.1 Company Profile of Beijing Baiya Joint Drug Research Institute Co., Ltd. 9.2.2 Pregabalin product introduction of Beijing Boya Joint Drug Research Institute Co., Ltd. 9.2.3 Pregabalin product business revenue of Beijing Baiya Joint Drug Research Institute Co., Ltd. (2019-2024) 9.2.4 SWOT analysis of Beijing Baiya Joint Drug Research Institute Co., Ltd. 9.2.5 News from Beijing Baiya Joint Drug Research Institute Co., Ltd. 9.3 Jichuan Pharmaceutical Group Co., Ltd. 9.3.1 Company Profile of Jichuan Pharmaceutical Group Co., Ltd. 9.3.2 Pregabalin product introduction of Jichuan Pharmaceutical Group Co., Ltd. 9.3.3 Jichuan Pharmaceutical Group Co., Ltd. Pregabalin product business revenue (2019-2024) 9.3.4 SWOT analysis of Jichuan Pharmaceutical Group Co., Ltd. 9.3.5 Jichuan Pharmaceutical Group Co., Ltd. News 9.4 Guangzhou Daguang Pharmaceutical Co., Ltd. 9.4.1 Company Profile of Guangzhou Daguang Pharmaceutical Co., Ltd. 9.4.2 Guangzhou Daguang Pharmaceutical Co., Ltd. Pregabalin product introduction 9.4.3 Pregabalin product business revenue of Guangzhou Daguang Pharmaceutical Co., Ltd. (2019-2024) 9.4.4 SWOT analysis of Guangzhou Daguang Pharmaceutical Co., Ltd. 9.4.5 Guangzhou Daguang Pharmaceutical Co., Ltd. News 9.5 Chengdu Huide Pharmaceutical Technology Co., Ltd. 9.5.1 Corporate Profile of Chengdu Huide Pharmaceutical Technology Co., Ltd. 9.5.2 Chengdu Huide Pharmaceutical Technology Co., Ltd. Pregabalin Product Introduction 9.5.3 Chengdu Huide Pharmaceutical Technology Co., Ltd. pregabalin product business revenue (2019-2024) 9.5.4 SWOT analysis of Chengdu Huide Pharmaceutical Technology Co., Ltd. 9.5.5 News from Chengdu Huide Pharmaceutical Technology Co., Ltd. 9.6 Baker Norton (Zhejiang) Pharmaceutical Co., Ltd. 9.6.1 Company Profile of Baker Norton (Zhejiang) Pharmaceutical Co., Ltd. 9.6.2 Pregabalin Product Introduction of Baker Norton (Zhejiang) Pharmaceutical Co., Ltd. 9.6.3 Pregabalin product business revenue of Baker Norton (Zhejiang) Pharmaceutical Co., Ltd. (2019-2024) 9.6.4 Baker Norton (Zhejiang) Pharmaceutical Co., Ltd. SWOT Analysis 9.6.5 Baker Norton (Zhejiang) Pharmaceutical Co., Ltd. News 9.7 East China Medicine (Xi’an) Bohua Pharmaceutical Co., Ltd. 9.7.1 Company Profile of Huadong Medicine (Xi’an) Bohua Pharmaceutical Co., Ltd. 9.7.2 Product introduction of Pregabalin by Huadong Medicine (Xi’an) Bohua Pharmaceutical Co., Ltd. 9.7.3 Huadong Medicine (Xi’an) Bohua Pharmaceutical Co., Ltd. Pregabalin product business revenue (2019-2024) 9.7.4 SWOT Analysis of Huadong Medicine (Xi’an) Bohua Pharmaceutical Co., Ltd. 9.7.5 Huadong Medicine (Xi’an) Bohua Pharmaceutical Co., Ltd. News 9.8 Hefei Enruite Pharmaceutical Co., Ltd. 9.8.1 Company Profile of Hefei Enruite Pharmaceutical Co., Ltd. 9.8.2 Hefei Enruite Pharmaceutical Co., Ltd. Pregabalin Product Introduction 9.8.3 Hefei Enruite Pharmaceutical Co., Ltd. Pregabalin product business revenue (2019-2024) 9.8.4 SWOT Analysis of Hefei Enruite Pharmaceutical Co., Ltd. 9.8.5 Hefei Enruite Pharmaceutical Co., Ltd. News 9.9 Sichuan Zilugong Pharmaceutical Co., Ltd. 9.9.1 Company Profile of Sichuan Zilugong Pharmaceutical Co., Ltd. 9.9.2 Pregabalin product introduction of Sichuan Zilugong Pharmaceutical Co., Ltd. 9.9.3 Sichuan Zilugong Pharmaceutical Co., Ltd. Pregabalin product business revenue (2019-2024) 9.9.4 SWOT Analysis of Sichuan Zilugong Pharmaceutical Co., Ltd. 9.9.5 Sichuan Zilugong Pharmaceutical Co., Ltd. News 9.10 Ningbo Meinuohua Tiankang Pharmaceutical Co., Ltd. 9.10.1 Company Profile of Ningbo Meinuohua Tiankang Pharmaceutical Co., Ltd. 9.10.2 Pregabalin product introduction of Ningbo Menohua Tiankang Pharmaceutical Co., Ltd. 9.10.3 Ningbo Menohua Tiankang Pharmaceutical Co., Ltd. Pregabalin product business revenue (2019-2024) 9.10.4 SWOT Analysis of Ningbo Meinuohua Tiankang Pharmaceutical Co., Ltd. 9.10.5 News from Ningbo Meinuohua Tiankang Pharmaceutical Co., Ltd. 9.11 Shandong Buchang Pharmaceutical Co., Ltd. 9.11.1 Company Profile of Shandong Buchang Pharmaceutical Co., Ltd. 9.11.2 Pregabalin product introduction of Shandong Buchang Pharmaceutical Co., Ltd. 9.11.3 Shandong Buchang Pharmaceutical Co., Ltd. Pregabalin product business revenue (2019-2024) 9.11.4 SWOT Analysis of Shandong Buchang Pharmaceutical Co., Ltd. 9.11.5 Shandong Buchang Pharmaceutical Co., Ltd. News 9.12 Aomei Pharmaceutical (Hainan) Co., Ltd. 9.12.1 Company Profile of Aomei Pharmaceutical (Hainan) Co., Ltd. 9.12.2 Pregabalin product introduction of Aomei Pharmaceutical (Hainan) Co., Ltd. 9.12.3 Aomei Pharmaceutical (Hainan) Co., Ltd. Pregabalin product business revenue (2019-2024) 9.12.4 SWOT analysis of Aomei Pharmaceutical (Hainan) Co., Ltd. 9.12.5 News from Aomei Pharmaceutical (Hainan) Co., Ltd. 9.13 Ningbo Shuangcheng Pharmaceutical Co., Ltd. 9.13.1 Company Profile of Ningbo Shuangcheng Pharmaceutical Co., Ltd. 9.13.2 Ningbo Shuangcheng Pharmaceutical Co., Ltd. Pregabalin Product Introduction 9.13.3 Ningbo Shuangcheng Pharmaceutical Co., Ltd. Pregabalin product business revenue (2019-2024) 9.13.4 SWOT Analysis of Ningbo Shuangcheng Pharmaceutical Co., Ltd. 9.13.5 Ningbo Shuangcheng Pharmaceutical Co., Ltd. News 9.14 Tiandi Hengyi Pharmaceutical Co., Ltd. 9.14.1 Company Profile of Tiandi Hengyi Pharmaceutical Co., Ltd. 9.14.2 Pregabalin product introduction of Tiandi Hengyi Pharmaceutical Co., Ltd. 9.14.3 Pregabalin product business revenue of Tiandi Hengyi Pharmaceutical Co., Ltd. (2019-2024) 9.14.4 SWOT Analysis of Tiandi Hengyi Pharmaceutical Co., Ltd. 90 9.14.5 Tiandi Hengyi Pharmaceutical Co., Ltd. News 90 9.15 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. 9.15.1 Corporate Profile of Chongqing Kerui Pharmaceutical (Group) Co., Ltd. 9.15.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Pregabalin Product Introduction 9.15.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Pregabalin product business revenue (2019-2024) 9.15.4 SWOT Analysis of Chongqing Kerui Pharmaceutical (Group) Co., Ltd. 9.15.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. News 9.16 Hunan Sailong Pharmaceutical (Changsha) Co., Ltd. 9.16.1 Company Profile of Hunan Sailong Pharmaceutical (Changsha) Co., Ltd. 9.16.2 Pregabalin product introduction of Hunan Sailong Pharmaceutical (Changsha) Co., Ltd. 9.16.3 Hunan Sailong Pharmaceutical (Changsha) Co., Ltd. Pregabalin product business revenue (2019-2024) 9.16.4 SWOT Analysis of Hunan Sailong Pharmaceutical (Changsha) Co., Ltd. 9.16.5 Hunan Sailong Pharmaceutical (Changsha) Co., Ltd. News 9.17 Qilu Pharmaceutical (Hainan) Co., Ltd. 9.17.1 Company Profile of Qilu Pharmaceutical (Hainan) Co., Ltd. 9.17.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Pregabalin Product Introduction 9.17.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Pregabalin product business revenue (2019-2024) 9.17.4 Qilu Pharmaceutical (Hainan) Co., Ltd. SWOT Analysis 9.17.5 Qilu Pharmaceutical (Hainan) Co., Ltd. News 10 Pregabalin industry supply chain analysis 10.1 Pregabalin industry chain 10.1.1 Analysis of downstream customers of Pregabalin products 10.1.2 Upstream raw materials in the pregabalin product industry chain 10.2 Pregabalin production process 10.3 Pregabalin product sales model and sales channels 11 Industry development opportunities and risks 11.1 Industry development opportunities and market drivers 11.2 Industry challenges and risks 11.3 Industry development trends 11.4 Analysis of Porter’s Five Forces Model 11.5 Important industry news 12 Analysis of the development environment of global and Chinese pregabalin industry 12.1 Market analysis of China’s overall economic environment 12.1.1 National economic and social development data in 2023 12.2 Impact of industry policies on pregabalin 12.3 Impact of the international situation on China’s pregabalin market 12.3.1 Russia-Ukraine conflict 12.3.2 The situation in the Red Sea in the Middle East 12.3.3 Sino-US trade friction 12.3.4 Others 13 Conclusion Related reports
|
|||||||||||||||||